Methamphetamine alters occludin expression via NADPH oxidase-induced oxidative insult and intact caveolae

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 2, 2012, Pages 362-375

  Park, Minseon ^a   Hennig, Bernhard ^b   Toborek, Michal ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Blood brain barrier; Brain endothelial cells; Drug abuse; Methamphetamine; Oxidative stress; Tight junctions

Indexed keywords

CAVEOLIN 1; CYTOCHROME B; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; METHAMPHETAMINE; MITOGEN ACTIVATED PROTEIN KINASE; OCCLUDIN; OCLN PROTEIN, MOUSE; P22(PHOX) PROTEIN, MOUSE; PIRB PROTEIN, MOUSE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL; ARTICLE; BRAIN; CAVEOLA; CELL LINE; CELL MOTION; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM CELL; GENETICS; METABOLISM; MOUSE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; CAVEOLAE; CAVEOLIN 1; CELL LINE; CELL MOVEMENT; CYTOCHROME B GROUP; ENDOTHELIAL CELLS; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; METHAMPHETAMINE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NADPH OXIDASE; OCCLUDIN; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RECEPTORS, IMMUNOLOGIC;

EID: 84856322811     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01320.x     Document Type: Article

References (56)

1. Cunha-Oliveira T, Rego AC, Oliveira CR. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs. Brain Res Rev. 2008; 58: 192-208.
2. Flora G, Lee Y, Nath A, et al Methamphetamine-induced TNF-α gene expression and activation of AP-1 in discrete regions of mouse brain. NeuroMolecular Med. 2002; 2: 71-85.
3. Lee YW, Hennig B, Yao J, et al Methamphetamine induces AP-1 and NF-kappaB binding and transactivation in human brain endothelial cells. J Neurosci Res. 2001; 66: 583-91.
4. Sharma HS, Kiyatkin EA. Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: An experimental study using light and electron microscopy. J Chem Neuroanat. 2009; 37: 18-32.
5. Ramirez SH, Potula R, Fan S, et al Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells. J Cereb Blood Flow Metab. 2009; 29: 1933-45.
6. Zhang X, Banerjee A, Banks WA, et al N-acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells. Brain Res. 2009; 1275: 87-95.
7. Huber JD, Egleton RD, Davis TP. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 2001; 24: 719-25.
8. Hirase T, Staddon J, Saitou M, et al Occludin as a possible determinant of tight junction permeability in endothelial cells. J Cell Sci. 1997; 110: 1603-13.
9. Tsukita S, Furuse M. Occludin and claudins in tight-junction strands: leading or supporting players? Trends Cell Biol. 1999; 9: 268-73.
10. Haorah J, Knipe B, Leibhart J, et al Alcohol-induced oxidative stress in brain endothelial cells causes blood-brain barrier dysfunction. J Leukoc Biol. 2005; 78: 1223-32.
11. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 2006; 6: 173-82.
12. Segal AW. How neutrophills kill microbes. Ann Rev Immunol. 2005; 23: 197-223.
13. Pagano PJ, Clark JK, Cifuentes-Pagano ME, et al Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensinI. Proc Natl Acad Sci USA. 1997; 94: 14483-8.
14. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H Oxidase: role in cardiovascular biology and disease. Circ Res. 2000; 86: 494-501.
15. Jones S, Hancock J, Jones O, et al The expression of NADPH oxidase components in human glomerular mesangial cells: detection of protein and mRNA for p47phox, p67phox, and p22phox. J Am Soc Nephrol. 1995; 5: 1483-91.
16. Mohazzab KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol Heart Circ Physiol. 1994; 266: H2568-72.
17. Jones SA, O'Donnell VB, Wood JD, et al Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol Heart Circ Physiol. 1996; 271: H1626-34.
18. Bayraktutan U, Draper N, Lang D, et al Expression of a functional neutrophil-type NADPH oxidase in cultured rat coronary microvascular endothelial cells. Cardiovasc Res. 1998; 38: 256-62.
19. Gorlach A, Brandes RP, Nguyen K, et al A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res. 2000; 87: 26-32.
20. Weksler BB, Subileau EA, Perriere N, et al Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 2005; 19: 1872-4.
21. Sekhar KR, Crooks PA, Sonar VN, et al NADPH Oxidase activity is essential for Keap1/Nrf2-mediated induction of GCLC in response to 2-indol-3-yl-methylenequinuclidin-3-ols. Cancer Res. 2003; 63: 5636-45.
22. Zhong Y, Smart EJ, Weksler B, et al Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling. J Neurosci. 2008; 28: 7788-96.
23. Ago T, Kuribayashi, Hiroaki H, et al Phosphorylation of p47phox directs phox homology domain from SH3 domain toward phosphoinositides, leading to phagocyte NADPH oxidase activation. Proc Natl Acad Sci USA. 2003; 100: 4474-9.
24. Rothe G, Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2', 7'-dichlorofluorescin. J Leukoc Biol. 1990; 47: 440-8.
25. Carter W, Narayanan P, Robinson J. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol. 1994; 55: 253-8.
26. Vilhardt F, van Deurs B. The phagocyte NADPH oxidase depends on cholesterol-enriched membrane microdomains for assembly. EMBO J. 2004; 23: 739-48.
27. Domier C, Simon S, Rawson R, et al A comparison of injecting and noninjecting methamphetamine users. J Psychoactive Drugs. 2000; 32: 229-32.
28. Schepers RJF, Oyler JM, Joseph RE, et al Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem. 2003; 49: 121-32.
29. Cook C, Jeffcoat A, Hill J, et al Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos. 1993; 21: 717-23.
30. Perez-Reyes M, White W, McDonald S, et al Clinical effects of methamphetamine vapor inhalation. Life Sci. 1991; 49: 953-9.
31. Cho A, Melega W, Kuczenski R, et al Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. Synapse. 2001; 39: 161-6.
32. Gawin F, Khalsa-Denison M. Is craving mood-driven or self-propelled? Sensitization and "street" stimulant addiction. NIDA Res Monogr. 1996; 163: 224-50.
33. Simon S, Richardson K, Dacey J, et al A comparison of patterns of methamphetamine and cocaine use. J Addict Dis. 2002; 21: 35-44.
34. Melega WP, Cho AK, Harvey D, et al Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling. Synapse. 2007; 61: 216-20.
35. Wu C-W, Ping Y-H, Yen J-C, et al Enhanced oxidative stress and aberrant mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells during methamphetamine induced apoptosis. Toxicol Appl Pharmacol. 2007; 220: 243-51.
36. Lau JWS, Senok S, Stadlin A. Methamphetamine-induced oxidative stress in cultured mouse astrocytes. Ann NY Acad Sci. 2000; 914: 146-56.
37. Potula R, Hawkins BJ, Cenna JM, et al Methamphetamine causes mitrochondrial oxidative damage in human T lymphocytes leading to functional impairment. J Immunol. 2010; 185: 2867-76.
38. Kumagai Y, Shimojo N. Possible mechanisms for induction of oxidative stress and suppression of systemic nitric oxide production caused by exposure to environmental chemicals. Environ Health Prev Med. 2002; 7: 141-50.
39. Miller AA, Drummond GR, Schmidt HHHW, et al NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries. Circ Res. 2005; 97: 1055-62.
40. Gluck MR, Moy LY, Jayatilleke E, et al Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment. J Neurochem. 2001; 79: 152-60.
41. Sakakibara A, Furuse M, Saitou M, et al Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol. 1997; 137: 1393-401.
42. van der Goes A, Wouters D, van der Pol SMA, et al Reactive oxygen species enhance the migration of monocytes across the blood-brain barrier in vitro. FASEB J. 2001; 15: 1852-4.
43. Lochhead JJ, McCaffrey G, Quigley CE, et al Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J Cereb Blood Flow Metab. 2010; 30: 1625-36.
44. Haorah J, Ramirez SH, Schall K, et al Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction. J Neurochem. 2007; 101: 566-76.
45. Schreibelt G, Kooij G, Reijerkerk A, et al Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J. 2007; 21: 3666-76.
46. Nimnual AS, Taylor LJ, Bar-Sagi D. Redox-dependent downregulation of Rho by Rac. Nat Cell Biol. 2003; 5: 236-41.
47. Gopalakrishnan S, Raman N, Atkinson SJ, et al Rho GTPase signaling regulates tight junction assembly and protects tight junctions during ATP depletion. Am J Physiol Cell Physiol. 1998; 275: C798-809.
48. Huang W, Eum SY, Andras IE, et al PPARα and PPARγ attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities. FASEB J. 2009; 23: 1596-606.
49. Stamatovic SM, Keep RF, Wang MM, et al Caveolae-mediated internalization of occludin and claudin-5 during CCL2-induced tight junction remodeling in brain endothelial cells. J Biol Chem. 2009; 284: 19053-66.
50. Yu Q, Zhang D, Walston M, et al Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice. Int Immunopharmacol. 2002; 2: 951-62.
51. Tocharus J, Khonthun C, Chongthammakun S, et al Melatonin attenuates methamphetamine-induced overexpression of pro-inflammatory cytokines in microglial cell lines. J Pineal Res. 2010; 48: 347-52.
52. Milovanova T, Chatterjee S, Hawkins BJ, et al Caveolae are an essential component of the pathway for endothelial cell signaling associated with abrupt reduction of shear stress. Biochim Biophys Acta. 2008; 1783: 1866-75.
53. Lee H, Volonte' D, Galbiati F, et al Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol Endocrinol. 2000; 14: 1750-75.
54. Quest AF, Leyton L, Parraga M. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease. Biochem Cell Biol. 2004; 82: 129-44.
55. Nag S, Manias JL, Stewart DJ. Expression of endothelial phosphorylated caveolin-1 is increased in brain injury. Neuropathol Appl Neurobiol. 2009; 35: 417-26.
56. Sun Y, Hu G, Zhang X, et al Phosphorylation of caveolin-1 regulates oxidant-induced pulmonary vascular permeability via paracellular and transcellular pathways. Circ Res. 2009; 105: 676-85.